Danone: Building A Nutrition Platform Behind A Dairy Valuation
Danone (DANOY) is evolving from a traditional dairy business into a higher-margin, science-based nutrition platform, with Specialized Nutrition now a key profit driver. Recent acquisitions in medical nutrition, gut health, and complete nutrition (Huel, Kate Farms, Akkermansia) strategically enhance DANOY's portfolio and channel access. Q1 2026 results showed resilient volume/mix growth, strong APAC performance, and maintained guidance, despite temporary headwinds in Specialized Nutrition.
Danone: Share Price Drop Makes Stock Attractive Again
Danone shows renewed investment appeal after a share price decline, with robust 2025 results and credible 2026 guidance. Q1 revenue grew 2.7% like-for-like, driven by balanced volume and pricing gains, supporting management's 3-5% full-year revenue growth target. Macroeconomic headwinds—persistent inflation, oil prices, and weakening consumer confidence—may constrain operating income growth despite hedging strategies.
Nestle and Danone face fresh scrutiny over infant formula recalls
Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public media questioned the speed of recalls of potentially harmful products.
Lifeway Foods: The End Of The Danone Support Is Not A Drawback
Lifeway (LWAY) delivered 37% organic revenue growth and margin expansion in Q1 2026, exceeding analyst expectations. Danone's complete exit via a secondary offering introduces short-term headwinds, but LWAY's recent acceleration appears independent of Danone. With 26 consecutive quarters of growth, no debt, and new fitness-focused products, LWAY remains well-positioned for continued expansion.
Danone S.A. (DANOY) Shareholder/Analyst Call Transcript
Danone S.A. (DANOY) Shareholder/Analyst Call Transcript
Danone S.A. (DANOY) Q1 2026 Sales/Trading Call Transcript
Danone S.A. (DANOY) Q1 2026 Sales/Trading Call Transcript
Danone Sales Grow as U.S. Momentum Returns
The company, which makes Activia yogurt and Evian water, reported like-for-like sales growth of 2.7% for the quarter.
Infant formula recall and impact of Iran war weigh on Danone Q1 sales
French food group Danone delivered first-quarter sales growth of 2.7%, which was slightly above expectations but marked a sharp slowdown from the previous quarter, as a recall of baby formula across Europe and the conflict in the Middle East hit specialised nutrition sales.
Danone CEO flags price uncertainty as Iran war escalates: ‘Nobody knows' how conflict will play out
Danone CEO Antoine de Saint-Affrique told CNBC that inflationary pressure from the Iran war may lead to higher food prices. "Nobody knows when [the war] is going to stop, and depending how the next two to four weeks are going to evolve, the outcome from a macroeconomic standpoint, is going to be very, very different," de Saint-Affrique said.
Danone (OTCMKTS:DANOY) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of Danone (OTCMKTS:DANOY - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, two have issued a buy rating and one has assigned
Danone Posts Revenue Rise Amid Infant Formula Recalls
Like-for-like sales rose 4.7% rise but a series of infant formula recalls have cast a pall over the food company's latest results.
Cereulide found in two baby formula products recalled by Danone, Switzerland says
Traces of a toxin that can cause nausea and vomiting were found in two types of infant formula recalled by France's Danone earlier this month, Swiss authorities said on Wednesday.
